Miranda MJA, Vega SDC, Arenas R

Language: Spanish
References: 25
Page: 146-150
PDF size: 123.89 Kb.

ABSTRACT

Background: sporotrichosis, a common mycosis, mainly affects South America (87.38%), followed by North America (11.62%), and 1% in Central America, the Caribbean, and Mexico. Diagnosis is confirmed through mycological studies.
Objectives: to determine the epidemiological, clinical, and mycological aspects of patients diagnosed with sporotrichosis at the Dr. Manuel Gea González General Hospital in Mexico City.
Methodology: observational, descriptive, and retrospective study conducted in the Mycology Section at the Dr. Manuel Gea González General Hospital from 1995 to 2023. The following variables were analyzed: gender, age, place of birth, profession, evolution, comorbidities, clinical form, and descriptive statistics were used.
Results: a total of 28 patients were gathered during the period 1995-2023, of which 35.71% were female and 64.28% were male, with ages ranging from nine to 84 years, showing a predominance in the 41-60 age group. The human clade of the Sporothrix schenckii complex was identified in 100% of cases.
Conclusions: sporotrichosis is a subcutaneous mycosis, with the highest incidence in males aged 41-60 years. Related occupational activities were housekeeping, students, and farmers, with a predominance of the lymphangitic form in the upper limbs and a rare disseminated form. In the pediatric population, it was more common in adolescents, affecting the upper limbs, followed by the face.

REFERENCES

1. Arenas R y Torres E, Micología médica ilustrada, 6ª ed., México,McGraw Hill, 2019, pp. 165-76.

2. Qin J y Junmin Z, Sporotrichosis, The New England Journal ofMedicine 2019; 380(8):771.

3. De Beer ZW, Duong TA y Wingfield MJ, The divorce of Sporothrixand Ophiostoma: solution to a problematic relationship,Stud Mycol 2016; 83:165-91.

4. Orofino-Costa R, Macedo PM, Rodrigues AM y Bernardes-Engemann AR, Sporotrichosis: an update on epidemiology,etiopathogenesis, laboratory and clinical therapeutics, An BrasDermatol 2017; 92(5):606-20.

5. Zurabian R y Hernández-Hernández F, Esporotricosis: la micosissubcutánea más frecuente de México, Rev Fac Med 2019;

6. 62(5):48-55.6. Queiroz-Telles F, Bonifaz A, Cognialli R, Lustosa BPR, VicenteVA y Ramírez-Marín HA, Sporotrichosis in children: case seriesand narrative review, Curr Fungal Infect Rep 2022; 16(2):33-46.

7. Toriello C, Brunner MC, Ruiz E, Duarte E, Pérez MA y Del RocíoReyes MM, Sporotrichosis in Mexico, Braz J Microbiol 2021;52:49-62.

8. López RE, Reyes MR, Pérez TA, Ruiz BE, Villagómez JC, MoraHM, Flores CA y Toriello C, Sporothrix schenckii complex andsporotrichosis, an emerging health problem, Future Microbiol2011; 6:85-102.

9. Aung AK, Teh BM, McGrath C y Thompson PJ, Pulmonary sporotrichosis:case series and systematic analysis of literature onclinic-radiological patterns and management outcomes, MedMycol 2013; 51:534-44.

10. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki Ty Li S, Global epidemiology of sporotrichosis, Med Mycol 2015;53:3-14.

11. Téllez MD, Batista-Duharte A, Portuondo D, Quinello C, Bonne-Hernández R y Carlos IZ, Sporothrix schenckii complex biology:environment and fungal pathogenicity, Microbiology 2014;160:2352-65.

12. Queiroz TF, Buccheri R y Benard G, Sporotrichosis in immunocompromisedhosts, J Fungi (Basilea) 2019; 5(1):8. 10.3390/jof5010008.

13. Sizar O y Talati R, Sporotrichosis. En StatPearls, 2023, Stat-Pearls Publishing.

14. Gremião IDF, Oliveira MME, De Miranda LHM, Freitas DFS y PereiraSA, Geographic expansion of sporotrichosis, Brazil, EmergInfect 2020; 26:621-4.

15. Yao L, Song Y, Zhou J-F, Cui Y y Li S-S, Epidemiological and clinicalcomparisons of paediatric and adult sporotrichosis in JilinProvince, China, Mycoses 2020; 63:308-13.

16. Ramírez-Soto MC, Sporotrichosis: the story of an endemicregion in Peru over 28 years (1985 to 2012), plos One 2015;10:e0127924.

17. Hernández-Castro R, Pinto-Almazán R, Arenas R, Sánchez-Cárdenas CD et al., Epidemiology of clinical sporotrichosisin the Americas in the last ten years, J Fungi (Basilea) 2022;8(6):588.

18. Mayorga-Rodríguez J, Mayorga-Garibaldi JL, Muñoz-Estrada VFet al., Esporotricosis: serie de 1 134 casos en una zona endémicade México, Med Cutan Iber Lat Am 2019; 47(1):24-8.

19. Padilla Desgarennes MC, Medina Castillo DE y Cortés LozanoN, Esporotricosis en edad pediátrica: experiencia del CentroDermatológico Pascua, Piel 2004; 19(7):359-63.

20. Arenas R, Dermatología. Atlas, diagnóstico y tratamiento, 8ª ed,México, McGraw Hill, 2023, pp. 486-91.

21. Niklitschek S, Porras N, González S y Romero W, Esporotricosis,Med Clin (Barcelona) 2015; 145(9):418.

22. Oliveira MM, Almeida-Paes R, Gutierrez-Galhardo MC y Zancope-Oliveira RM, Molecular identification of the Sporothrixschenckii complex, Rev Iberoam Micol 2014; 31(1):2-6.

23. Pinto-Almazán R, Sandoval-Navarro KA, Damián-Magaña EJ,Arenas R et al., Relationship of sporotrichosis and infected patientswith hiv-aids: an actual systematic review, J Fungi (Basilea)2023; 9(4):396.

24. Da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, VettoratoG y Weber A, Epidemiology of sporotrichosis: a study of 304cases in Brazil, J Am Acad Dermatol 2005; 52(3 Pt 1):451-9.

25. Rabello VBS, Almeida MA, Bernardes-Engemann AR, Almeida-Paes R, De Macedo PM y Zancopé-Oliveira RM, The historicalburden of sporotrichosis in Brazil: a systematic review of casesreported from 1907 to 2020, Braz J Microbiol 2022; 53(1):231-44.